NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) recently closed its previously announced license and acquisition of a portfolio of regenerative biomaterial products from Celularity Inc. (NASDAQ: CELU) and launched a …
NEXGEL Closes Celularity Asset Deal, Launches BioNX Surgical Read More